Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 568

1.

Adverse event reports following yellow fever vaccination.

Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB.

Vaccine. 2008 Nov 11;26(48):6077-82. doi: 10.1016/j.vaccine.2008.09.009. Epub 2008 Sep 20.

PMID:
18809449
2.

Adverse event reports following yellow fever vaccination, 2007-13.

Lindsey NP, Rabe IB, Miller ER, Fischer M, Staples JE.

J Travel Med. 2016 Jul 4;23(5). doi: 10.1093/jtm/taw045. Print 2016 May.

PMID:
27378369
3.

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.

MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. Erratum in: MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(06):113.

4.

Yellow fever vaccination: how much is enough?

Massad E, Coutinho FA, Burattini MN, Lopez LF, Struchiner CJ.

Vaccine. 2005 Jun 10;23(30):3908-14. Epub 2005 Apr 2.

PMID:
15917112
5.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
6.

Risk of fatal adverse events associated with 17DD yellow fever vaccine.

Struchiner CJ, Luz PM, Dourado I, Sato HK, Aguiar SG, Ribeiro JG, Soares RC, Codeço CT.

Epidemiol Infect. 2004 Oct;132(5):939-46.

7.

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events.

Khromava AY, Eidex RB, Weld LH, Kohl KS, Bradshaw RD, Chen RT, Cetron MS; Yellow Fever Vaccine Safety Working Group.

Vaccine. 2005 May 9;23(25):3256-63.

PMID:
15837230
8.

Prevention of yellow fever in persons traveling to the tropics.

Monath TP, Cetron MS.

Clin Infect Dis. 2002 May 15;34(10):1369-78. Epub 2002 Apr 25. Review. Erratum in: Clin Infect Dis 2002 Jul 1;35(1):110.

PMID:
11981733
9.

Review of the risks and benefits of yellow fever vaccination including some new analyses.

Monath TP.

Expert Rev Vaccines. 2012 Apr;11(4):427-48. doi: 10.1586/erv.12.6. Review.

PMID:
22551029
10.

[Yellow fever vaccination: update on rare and severe adverse effects].

Receveur MC, Bruyand M, Pistone T, Malvy D.

Med Mal Infect. 2009 Apr;39(4):234-41. doi: 10.1016/j.medmal.2008.11.013. Epub 2009 Jan 23. French.

PMID:
19167852
11.

Yellow fever vaccination: some thoughts on how much is enough [Vaccine 23 (2005) 3908-3914].

Martins RM, Galler R, Freire MS, Camacho LA, de Lourdes S Maia M, Homma A.

Vaccine. 2007 Jan 2;25(1):10-1. Epub 2006 Jan 18.

PMID:
16448728
12.

Evaluation of two yellow fever vaccines for routine immunization programs in Argentina.

Ripoll C, Ponce A, Wilson MM, Sharif N, Vides JB, Armoni J, Teuwen DE.

Hum Vaccin. 2008 Mar-Apr;4(2):121-6. Epub 2007 Oct 26.

PMID:
18382132
13.

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.

Breugelmans JG, Lewis RF, Agbenu E, Veit O, Jackson D, Domingo C, Böthe M, Perea W, Niedrig M, Gessner BD, Yactayo S; YF AEFI group.

Vaccine. 2013 Apr 3;31(14):1819-29. doi: 10.1016/j.vaccine.2013.01.054. Epub 2013 Feb 7.

PMID:
23395587
14.

Safety of the yellow Fever vaccine: a retrospective study.

Nordin JD, Parker ED, Vazquez-Benitez G, Kharbanda EO, Naleway A, Marcy SM, Molitor B, Kuckler L, Baggs J.

J Travel Med. 2013 Nov-Dec;20(6):368-73. doi: 10.1111/jtm.12070. Epub 2013 Oct 10.

15.

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.

Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT.

Pediatr Infect Dis J. 2004 Apr;23(4):287-94. Review.

PMID:
15071280
16.

Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.

Niu MT, Ball R, Woo EJ, Burwen DR, Knippen M, Braun MM; VAERS Working Group.

Vaccine. 2009 Jan 7;27(2):290-7. doi: 10.1016/j.vaccine.2008.10.044. Epub 2008 Nov 6.

PMID:
18992783
17.

Anaphylaxis from yellow fever vaccine.

Kelso JM, Mootrey GT, Tsai TF.

J Allergy Clin Immunol. 1999 Apr;103(4):698-701.

PMID:
10200022
18.

Age-related risk of adverse events following yellow fever vaccination in Australia.

Lawrence GL, Burgess MA, Kass RB.

Commun Dis Intell Q Rep. 2004;28(2):244-8. Erratum in: Commun Dis Intell. 2004;28(3):348.

19.

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil.

Galler R, Pugachev KV, Santos CL, Ocran SW, Jabor AV, Rodrigues SG, Marchevsky RS, Freire MS, Almeida LF, Cruz AC, Yamamura AM, Rocco IM, da Rosa ES, Souza LT, Vasconcelos PF, Guirakhoo F, Monath TP.

Virology. 2001 Nov 25;290(2):309-19.

20.

Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, Ward BJ, West DJ.

Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):825-40. Review.

PMID:
15386719

Supplemental Content

Support Center